Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00975923 · ClinicalTrials.gov registry record · NA
Safe Critical Care: Testing Improvement Strategies
A NA study of Ventilator Associated Pneumonia and Central Line-Associated Bloodstream Infection (CLABSI), sponsored by Vanderbilt University.
- Completed
- Registry status
- NA
- Development phase
- 59
- Enrollment target
- 1
- Study location
NCT00975923: Completed NA study of Ventilator Associated Pneumonia and Central Line-Associated Bloodstream Infection (CLABSI), sponsored by Vanderbilt University.
NCT00975923 is a NA study of Ventilator Associated Pneumonia and Central Line-Associated Bloodstream Infection (CLABSI) that has completed, run by Vanderbilt University. The registered enrollment target is 59 participants, below the 108-participant average among 7 other Ventilator Associated Pneumonia trials with a reported enrollment target (45% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00975923, a NA study of Ventilator Associated Pneumonia and Central Line-Associated Bloodstream Infection (CLABSI), has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- NA
- Development phase
- 59 participants
- Enrollment target
- 1
- Study location
Study Summary
One group of hospitals participated in a collaborative approach for healthcare quality improvement while another group was provided only a tool kit. The investigators' objective was to determine if the Collaborative would perform better at preventing central line-associated bloodstream infections (CLABSI) and ventilator-associated pneumonias (VAP). Hospitals were randomized to the Tool Kit or Collaborative conditions. The investigators' study evaluated the effects on care processes and outcomes of a multi-institutional quality improvement initiative focused on preventing hospital associate infections. The investigators' hypothesis was that the strategies for implementing safe critical care practice will differ in level of achievement whereby the Collaborative group will perform better than the Tool Kit group. The outcome measure comprised clinical event rates and an index of safe practices that represent a bundling of key process measures related to evidence-based practices for preventing catheter-related blood-stream infections and ventilator-associated pneumonia in the intensive care unit.
Primary Outcome
Central line associated bloodstream infections(CLABSI) and ventilator associated pneumonias (VAP) using Centers for Disease Control and Prevention definitions as number of events per 1,000 device days, data collection and surveillance methods.
Conditions Studied
Interventions
- BEHAVIORAL Collaborative Group
- BEHAVIORAL Tool Kit
Study Locations (1)
Tennessee
- HCA Hospital Corporation of America - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 59 participants |
| Start Date | 2006-02 |
| Est. Completion | 2008-04 |
| Phase | NA |
What the finished NCT00975923 record still lists
NCT00975923 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 59 participants, a relatively small participant target, below the 108-participant average among 7 other Ventilator Associated Pneumonia trials with a reported enrollment target (45% lower).
The record links to 2 conditions, with Ventilator Associated Pneumonia appearing as the primary indexed condition, and to 2 interventions - of which Collaborative Group is the first listed.
NCT00975923 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT00975923 about?
NCT00975923 is a clinical study titled "Safe Critical Care: Testing Improvement Strategies". One group of hospitals participated in a collaborative approach for healthcare quality improvement while another group was provided only a tool kit. The investigators' objective was to determine if the Collaborative would perform better at preventing central line-associated bloodstream infections (C...
What is the current status of trial NCT00975923?
This trial is currently completed. It is a NA study. The enrollment target is 59 participants. The study started on 2006-02. Estimated completion is 2008-04.
What conditions does trial NCT00975923 study?
This clinical trial studies the following conditions: Ventilator Associated Pneumonia, Central Line-Associated Bloodstream Infection (CLABSI).
What interventions are being tested in trial NCT00975923?
The interventions under investigation include: Collaborative Group (BEHAVIORAL), Tool Kit (BEHAVIORAL).
Who is sponsoring clinical trial NCT00975923?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00975923 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ventilator Associated Pneumonia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Frequent Standardized Oral Care Using Human Milk in the Neonatal Intensive Care Unit
RECRUITING · NA
-
Macrophage Programing in Acute Lung Injury: MiniBAL
RECRUITING · NA
-
Frequent Standardized Oral Care to Improve Health Outcomes in Premature Infants in the Neonatal Intensive Care Unit
ACTIVE NOT RECRUITING · NA
-
Impact of Using Mini-Bronchoalveolar Lavage as a Diagnostic Test for Ventilator-Associated Pneumonia
COMPLETED · NA
-
Pneumonia Direct Pilot
COMPLETED
-
Aerosolized Antibiotics and Respiratory Tract Infection in Patients on Mechanical Ventilation
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03801083 · 59 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers
- NCT04332367 · 59 participants · Phase 2
Carboplatin, Taxane And Ramucirumab for Patients With NSCLC After Pemetrexed or Pembrolizumab Maintenance
- NCT05489575 · 59 participants · NA
CPAP for the Treatment of Supine Hypertension
- NCT06721689 · 59 participants · Phase 1
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia